GOLDENWELL BIOTECH, INC.
No SEC Form 4 filings for $GWLL in the last 30 days.
See all $GWLL insider activity →Ming Zhou disclosed a 20.2% stake in Goldenwell Biotech (GWLL) after receiving 20M shares from CEO Shuang Liu. She joined the board on Oct. 8, 2026, and may buy or sell shares based on market conditions. Zhou, a business executive, plans to review her investment over time.
GOLDENWELL BIOTECH, INC. (GWLL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 8, 2026, the board of directors of Goldenwell Biotech, Inc. (the “Company”) appointed Ming Zhou as a director. T
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning GWLL (GOLDENWELL BIOTECH, INC.). Coverage has skewed bearish: 0 bullish, 2 neutral, and 1 bearish.
Recent GWLL coverage spans financial news and corporate actions.
Significant insider ownership and board appointment may influence investor sentiment and governance.
Significant dilution from a large share gift and new board member may pressure the stock.
AlphAI scores every news story that mentions GWLL with an AI model for sentiment and relevance, and aggregates insider trades from GOLDENWELL BIOTECH, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Ming Zhou disclosed a 20.2% stake in Goldenwell Biotech (GWLL) after receiving 20M shares from CEO Shuang Liu. She joined the board on Oct. 8, 2026, and may buy or sell shares based on market conditions. Zhou, a business executive, plans to review her investment over time.
1 min readGOLDENWELL BIOTECH, INC. (GWLL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 8, 2026, the board of directors of Goldenwell Biotech, Inc. (the “Company”) appointed Ming Zhou as a director. T
2 min read
